Fitbit launched a large-scale study to validate the use of its technology to detect atrial fibrillation. The company plans to enroll hundreds of thousands of people into the virtual study.
Scripps Research launched a new study to see if data collective from wearable devices could be used to track flu-like illnesses, including Covid-19. In January, Scripps published a retrospective study using a similar methodology showing that sleep and resting heart rate data from Fitbits were correlated with the number of patients reporting influenza-like illness.
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
Fitbit saw its margins decline from last year, after it rolled out a series of lower-priced devices to woo new users. The company is on the verge of being acquired by Google for $2.1 billion, with the deal pending regulators’ approval.
A new study by the Scripps Research Translational Institute suggests Fitbits could be used to detect the flu. By tracking resting heart rate and activity levels, researchers said Fitbits could improve detection of outbreaks at the state level.
Patients with type 2 diabetes on WellCare of Georgia’s Medicaid plan will be able to receive the wearables as part of their plan starting in 2020.
We spoke to investors and analysts to figure out why Google is buying Fitbit, a company that hasn't made much of a dent in the healthcare world.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Software designed to detect atrial fibrillation - estimated to affect 8 million Americans this year - will be created for Fitbit and submitted to the FDA for approval.
While the devices themselves will be free for users, additional health coaching services and software offerings will require a monthly fee.
With the new feature, members have the ability to link their Apple, Fitbit or Samsung smartwatches to the company's app to receive health information on their wrist and share activity information back with Livongo to better personalize activity and health suggestions.
MedCity News caught up with Omron Healthcare CEO Ranndy Kellogg at the the AdvaMed Digital MedTech Conference in San Francisco to speak about the company's new products, emerging business lines and how collaboration with other companies have driven recent innovation.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The product (codenamed Dylan) is being developed by Amazon's hardware development team Lab126 and its Alexa division. Designed to be worn on the wrist, the device seemingly has a form factor similar to a smartwatch.
Last year, Rahman told Recode that he was reviving the company as Jawbone Health, moving the focus of the company away from fitness tracking and toward remote patient monitoring.
More than 230,000 people have started the process of joining the research program and more than 142,000 have completed the program's first research protocol.
CTA's working group, which includes more than 30 different organizations, is an effort to bring stakeholders together to create common understanding around AI definitions, proper data management and ethical considerations like bias and privacy.
The company in betting hard on its Fitbit Health Solutions enterprise business line as it shifts its business model from device sales to recurring software and services revenue. The business line is projected to hit $100 million in revenue in 2019.